Amanda Hayward
Chairman at Hoba Therapeutics ApS
Profile
Amanda Hayward is currently the Chairman at Hoba Therapeutics ApS.
Previously, she worked as a Director at Optherion, Inc., a Venture Partner at Connecticut Innovations, Inc., and the Chief Financial Officer at Renetx Bio, Inc. She also worked as a Senior Vice President at Scheer & Co., Inc. from 2000 to 2015.
Dr. Hayward holds a doctorate degree from Texas Tech University and an undergraduate degree from The University of Sheffield.
Amanda Hayward active positions
| Companies | Position | Start |
|---|---|---|
Hoba Therapeutics ApS
 Hoba Therapeutics ApS BiotechnologyHealth Technology Hoba Therapeutics ApS engages in research and experimental development in biotechnology. The firm’s purpose is commercialization of pharmaceuticals and biotechnology services. The company was founded on November 28, 2016 and is headquartered in Copenhagen, Denmark. | Chairman | - |
Former positions of Amanda Hayward
| Companies | Position | End |
|---|---|---|
Scheer & Co., Inc.
 Scheer & Co., Inc. Investment ManagersFinance Scheer & Co., Inc. ( Scheer ) is a venture capital firm. The firm is founded in 1981 by David I. Scheer. The firm is headquartered in Connecticut, United States. | Private Equity Analyst | 25/05/2010 |
Connecticut Innovations, Inc.
 Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Private Equity Investor | - |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Director of Finance/CFO | - |
Optherion, Inc.
 Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Corporate Officer/Principal | - |
Training of Amanda Hayward
| Texas Tech University | Doctorate Degree |
| The University of Sheffield | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Scheer & Co., Inc.
Scheer & Co., Inc. Investment ManagersFinance Scheer & Co., Inc. ( Scheer ) is a venture capital firm. The firm is founded in 1981 by David I. Scheer. The firm is headquartered in Connecticut, United States. | Finance |
Optherion, Inc.
Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Connecticut Innovations, Inc.
Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Finance |
Hoba Therapeutics ApS
Hoba Therapeutics ApS BiotechnologyHealth Technology Hoba Therapeutics ApS engages in research and experimental development in biotechnology. The firm’s purpose is commercialization of pharmaceuticals and biotechnology services. The company was founded on November 28, 2016 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Amanda Hayward
